Oral Administration of Tissue-Targeted TLR7 Agonists for Immune Oncology

Time: 4:30 pm
day: Day One

Details:

  • Unpicking the mechanistic studies of our tissue-targeted approaches,
  • Exploring the preclinical models
  • Assessing cytokine responses as it pertains to tissue distribution and residence time

Speakers: